Geoffrey Wolf

Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA.

AgPlus Diagnostics Ltd. develops technology solutions. It focuses on the development program at Ag and delivers diagnostic platform technology. The firm also offers market applications including human clinical, human non-clinical, sports medicine, veterinary, environmental, and military. The company was founded by Rob Porter and Mateus Symanski in 2006 and is headquartered in Sharnbrook, the United Kingdom.